Biotech Stocks (IBB) Get Thrown Out with Bath Water
Tweet
Share
E-mail
Biotech Companies sold off today amidst a broader market sell off. But the tumble may have more to do with Regeneron Pharmaceuticals, Inc.'s (NASDAQ: REGN) drug Eylea than the weaker than expected U.S. jobs number.
Regeneron shares tumbled nearly 9 percent on Friday after a survey by Cowen said Eylea was decelerating in terms of patient add-ons. Shares of Regen are up 140 percent so far this year.
Shares of Amgen Inc. (NASDAQ: AMGN) were also lower today, shedding 2.5 percent in what looks like a reaction to the jobs number and general risk aversion.
Regeneron shares tumbled nearly 9 percent on Friday after a survey by Cowen said Eylea was decelerating in terms of patient add-ons. Shares of Regen are up 140 percent so far this year.
Shares of Amgen Inc. (NASDAQ: AMGN) were also lower today, shedding 2.5 percent in what looks like a reaction to the jobs number and general risk aversion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crude Inventory Declined 6.4 Million Barrels Last Week
- Invesco (IVZ) PT Lowered to $19.50 at TD Cowen
- TD Cowen Reiterates Buy Rating on Edwards Lifesciences (EW)
Create E-mail Alert Related Categories
ETFsRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
